pillbase.ru

AUSTEDO XR

Active substance: deutetrabenazine

TABLET, FILM COATED, EXTENDED RELEASE · DEUTETRABENAZINE 30 mg/1

United StatesActive

Marketing holder: Teva Neuroscience, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Austedo
    deutetrabenazine
    EMEA/H/C/006371
    Teva GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-a737-7833-b1e0-f83372f3145b,01a1208d-8f6a-759f-81f0-af080eeb4f53,01a1208d-8f74-7355-b237-0f5d587fb6cb,01a1208d-8f78-7ee0-b107-0c53c12c99d6,01a1208e-bfc3-76d5-84ba-baa7206223dd;count=13 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
68546-473
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 68546-473 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 68546-473 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 68546-473 · Verified 2026-10-09 · open in source